Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × Cytarabine × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 4 Neuroblastoma 2 Meningeal Carcinomatosis 2 Central Nervous System Neoplasms 2 Brain Neoplasms 2 Vasculitis, Central Nervous System 1 Thrombocytopenia 1 Stiff-Person Syndrome 1 Recurrence 1 Rasmussen subacute encephalitis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Opsoclonus-Myoclonus Syndrome 1 Neurotoxicity Syndromes 1 Neuromyelitis Optica 1 Neurofibromatosis 1 1 Myasthenia Gravis 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Lambert-Eaton Myasthenic Syndrome 1 Intraocular Lymphoma 1 HIV Infections 1 Ependymoma 1 Drug-Related Side Effects and Adverse Reactions 1 Breast Neoplasms 1 Autoimmune Diseases of the Nervous System 1 Autoimmune Diseases 1

Interventions

Trastuzumab 15 Radiosurgery 14 Magnetic Resonance Spectroscopy 13 Capecitabine 12 Radiotherapy 11 Specimen Handling 9 Lapatinib 9 trastuzumab deruxtecan 8 Temozolomide 8 Cyclophosphamide 8 Docetaxel 6 Cisplatin 6 Therapeutics 5 Spinal Puncture 5 Paclitaxel 5 Gemcitabine 5 Flow Cytometry 5 tucatinib 4 sacituzumab govitecan 4 pembrolizumab 4 paclitaxel-Angiopep-2 conjugate 4 eribulin 4 Methotrexate 4 Fluorodeoxyglucose F18 4 Dexamethasone 4 Bevacizumab 4 temsirolimus 3 pyrotinib 3 fludarabine 3 durvalumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01645839 2019-06-12

DEPOSEIN

Centre Oscar Lambret

Phase 3 Completed

Breast Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡